文献速递腹部MR

肝移植后发生肝细胞癌的钆塞酸增强磁共振成像特征

Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants.
PubMed 文献 · Eur Radiol · 2016-12-12

比较肝移植后复发肝细胞癌患者(25例)与非移植对照组(25例)的钆塞酸增强MRI强化模式,移植组不典型强化比例显著更高(64.0% vs 20.0%,p=0.004),但强化模式与总生存期及至肿瘤复发时间无显著差异(p>0.05)。

要点

  • 肝移植后复发肝细胞癌在钆塞酸增强MRI上常表现为不典型强化(16/25,64.0%)。
  • 不典型强化包括缺乏延迟期廓清或出现类似胆管癌的征象。
  • 复发肝细胞癌的强化模式与总生存期及至肿瘤复发时间无显著差异(p>0.05)。

核心结论

  • 肝移植后复发的肝细胞癌在钆塞酸增强MRI上频繁显示不典型强化,但强化模式未显著影响总生存期和至肿瘤复发时间(p>0.05)。

研究设计与样本

  • 比较肝移植后复发肝细胞癌患者25例(移植组)与手术证实肝细胞癌的非移植患者25例(对照组)的钆塞酸增强MRI强化模式,采用log-rank检验分析移植组总生存期和至肿瘤复发时间。

关键影像表现/征象

  • 移植组肝细胞癌不典型强化模式显著多于对照组(16/25,64.0% vs 5/25,20.0%,p=0.004)。
  • 不典型强化表现为缺乏延迟期廓清或出现类似胆管癌的征象(动脉期边缘强化和肝胆期靶征)。

诊断标准与关键数值

  • 典型强化定义为:1)动脉期强化和延迟期廓清;2)无胆管癌典型特征(动脉期边缘强化和肝胆期靶征)。

临床应用与阅片要点

  • 肝移植后出现的肝细胞癌在钆塞酸增强MRI上常表现为不典型强化,阅片时需注意缺乏延迟期廓清或类似胆管癌征象的可能。
  • 复发肝细胞癌的强化模式与总生存期及至肿瘤复发时间无显著差异(p>0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Characteristics of hepatocellular carcinoma (HCC) on magnetic resonance (MR) images were compared in patients who did or did not undergo liver transplantation (LT), and we evaluated the relationship of these findings with overall survival (OS) and time-to-tumour recurrence (TTR) after transplantation.

METHODS: The enhancement pattern of gadoxetic acid-enhanced MR images of 25 patients with recurrent HCCs (LT group) and 25 surgically confirmed HCC patients in the non-transplanted (control) group were compared. Typical enhancement was defined as 1) arterial enhancement and delayed wash-out and 2) absence of typical features of cholangiocarcinoma consisting of arterial rim enhancement and target appearance on hepatobiliary phase images. OS and TTR were analyzed in the LT group according to these patterns using the log-rank test.

RESULTS: HCCs in the LT group significantly more often had an atypical enhancement pattern (16/25, 64.0%) than those in the control group (5/25, 20.0%; p = 0.004). However, OS and TTR did not differ significantly according to these enhancement patterns of recurrent HCC (p > 0.05).

CONCLUSION: Although enhancement patterns of recurrent HCC in transplanted liver did not affect OS and TTR, these HCCs that arise after LT frequently revealed atypical enhancement on gadoxetic acid-enhanced MR imaging.

KEY POINTS: • Recurrent HCCs after LT showed atypical enhancement on gadoxetic acid-enhanced MRI. •They showed absence of delayed wash-out or cholangiocarinoma-like features. • Enhancement patterns of recurrent HCCs did not affect OS and TTR.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kim M, Kang TW, Jeong WK, et al. Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants. Eur Radiol. 2016. PMID: 27957635. doi:10.1007/s00330-016-4662-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。